| Discovery Research Projects | University of California, Los Angeles | Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells |
$250,000 |
| Quest – Discovery Stage Research Projects | University of California, Los Angeles | Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells |
$1,402,662 |
| Quest – Discovery Stage Research Projects | University of California, Los Angeles | Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer |
$1,404,000 |
| Therapeutic Translational Research Projects | University of California, Los Angeles | Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy |
$5,601,600 |
| Therapeutic Translational Research Projects | University of California, Los Angeles | HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma |
$5,281,199 |
| Therapeutic Translational Research Projects | University of California, Los Angeles | Stem Cell-Based iNKT Cell Therapy for Cancer |
$6,956,775 |
| Basic Biology V | University of California, Los Angeles | Differentiation of Human Hematopoietic Stem Cells into iNKT Cells |
$614,400 |
